Twist Bioscience Corporation TWST Reportable Segment — Restructuring and other costs

Similar metrics at other companies

MSMReportable Segment — Restructuring and other costs

$2.45M+74.5%

GXOReportable Segment — Restructuring costs and other

$3M-82.4%

HNGEReportable Segment — Restructuring, acquisition and other expenses

$1.34M-41.4%

CDNSReportable Segment — Restructuring

-$5K+95.4%

ROLReportable Segment — Restructuring costs

$0—

PYPLReportable Segment — Restructuring and other

$74M+12.1%

Questions, answered.

What is Twist Bioscience Corporation's reportable segment — restructuring and other costs?

Twist Bioscience Corporation (TWST) reported reportable segment — restructuring and other costs of $0 in Q3 2025.

What is the long-term trend for Twist Bioscience Corporation's reportable segment — restructuring and other costs?

Over 2 years (2023 to 2025), Twist Bioscience Corporation's reportable segment — restructuring and other costs has grown at a -100.0% compound annual growth rate (CAGR), from $9.38M to $0.

What does reportable segment — restructuring and other costs mean?

This metric captures non-recurring expenses associated with organizational changes, such as workforce reductions, facility consolidations, or strategic realignments within the reportable segment. These costs are typically excluded from core operating performance analysis to better understand the underlying business trends. High levels of these costs may indicate significant operational shifts or management efforts to improve long-term efficiency.